Cautious tape with VIX at 17.5, 10Y at 4.56%, S&P -0.5%, DXY +0.3%. Selective strength across the 494-ticker cannabis universe — 14 advancing, 19 declining (42% up). Leaders and laggards: GNLN +4.8%, CAN -7.9%. Analyst consensus tilts bullish — 45 Buys, 5 Holds, 7 Sells. Widest implied upside: QNTM to $12.50 (+277%). Elevated short interest concentrated in OGI at 10.4 days-to-cover.
CIN TAKE
Analyst conviction is building faster than the macro will allow it to be paid. Buy-side upside targets look right on 12-month math but wrong on 12-week timing. Selective, catalyst-anchored positioning only — no broad-beta adds until macro cracks lower.
The full institutional brief on today's read — thesis, forecasts, names & levels, risk matrix, positioning map, and the CIN Take. Emailed to you and shown here.
Forecasts
Time-horizoned, falsifiable, tickered.
Risk Matrix
4–6 risks, each labeled by severity and mechanism.
Positioning Map
How generalist, sector specialist, and retail allocator lean.
CIN Recommendation
How the desk is leaning today.
Deeper Dive
A copy has been emailed to you. · CIN Editorial Desk